Illumina takes aim at rival in gene sequencing spat

Illumina claims Element’s AVITI sequencing platforms includes patented tech | Biotech firm alleges it infringes its MiSeq and MiniSeq system | Start-up founded by former Illumina employees.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

NanoString to pay 10x Genomics $68m in global settlement

15 May 2025 Biotech rivals agree global patent cross-licences and end all litigation | 10x ‘expects’ to receive $68m plus royalties on sales of its spatial biology products.

Americas

Medical company sees $452m trade secrets award cut by 87%

29 April 2025 US district judge reduces award payable to Insulet by EOFlow to $59.4m l Dispute concerns wearable insulin patch pumps l Injunction remains but with allowance for users to access device temporarily.

More on this story

Europe

NanoString to pay 10x Genomics $68m in global settlement

15 May 2025 Biotech rivals agree global patent cross-licences and end all litigation | 10x ‘expects’ to receive $68m plus royalties on sales of its spatial biology products.

Americas

Medical company sees $452m trade secrets award cut by 87%

More on this story

Europe

NanoString to pay 10x Genomics $68m in global settlement

15 May 2025 Biotech rivals agree global patent cross-licences and end all litigation | 10x ‘expects’ to receive $68m plus royalties on sales of its spatial biology products.

Americas

Medical company sees $452m trade secrets award cut by 87%